» Articles » PMID: 1645339

Protein Kinase C As a Mediator of High Density Lipoprotein Receptor-dependent Efflux of Intracellular Cholesterol

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1991 Jun 5
PMID 1645339
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction of high density lipoproteins (HDL) with the HDL receptor stimulates the translocation of cholesterol from intracellular pools to the plasma membrane where the cholesterol becomes available for removal by appropriate acceptors. The role of signal transduction through protein kinase C in HDL receptor-dependent cholesterol translocation and efflux was examined using cholesterol-loaded cultured human skin fibroblasts. Treatment of cells with HDL3 activated protein kinase C, demonstrated by a transient increase in membrane associated kinase activity. Kinase activation appeared to be dependent on binding of HDL3 to the HDL receptor, since tetranitromethane-modified HDL3, which does not bind to the receptor, was without effect. Translocation of intracellular sterol to the plasma membrane was stimulated by treatment of cells with the protein kinase C activators, dioctanoylglycerol and phorbol myristic acetate, and the calcium ionophore A23187. Conversely, treatment of cells with sphingosine, a protein kinase C inhibitor, reduced HDL3-mediated translocation and efflux of intracellular sterols. However, sphingosine had no effect on efflux of labeled cholesterol derived from the plasma membrane. Down-regulation of cellular protein kinase C activity by long term incubation with phorbol esters also inhibited HDL3-mediated efflux of intracellular sterols and abolished the ability of sphingosine to further inhibit HDL3-mediated efflux. These studies support the conclusion that HDL receptor-mediated translocation and efflux of intracellular cholesterol occurs through activation of protein kinase C.

Citing Articles

Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.

Kothari V, Ho T, Cabodevilla A, He Y, Kramer F, Shimizu-Albergine M Circ Res. 2024; 135(2):335-349.

PMID: 38828596 PMC: 11223987. DOI: 10.1161/CIRCRESAHA.123.323100.


Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.

He Y, Pavanello C, Hutchins P, Tang C, Pourmousa M, Vaisar T Circulation. 2023; 149(10):774-787.

PMID: 38018436 PMC: 10913861. DOI: 10.1161/CIRCULATIONAHA.123.065959.


HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.

Costacou T, Vaisar T, Miller R, Davidson W, Heinecke J, Orchard T medRxiv. 2023; .

PMID: 37986833 PMC: 10659494. DOI: 10.1101/2023.11.06.23298165.


Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs.

He Y, Pavanello C, Hutchins P, Tang C, Pourmousa M, Vaisar T medRxiv. 2023; .

PMID: 37961344 PMC: 10635269. DOI: 10.1101/2023.11.03.23297986.


Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.

Ronsein G, Vaisar T, Davidson W, Bornfeldt K, Probstfield J, OBrien K Arterioscler Thromb Vasc Biol. 2021; 41(8):2330-2341.

PMID: 34134520 PMC: 8295224. DOI: 10.1161/ATVBAHA.121.316278.